New Village Medical at Walgreens clinics to open in Texas, Arizona and Florida, following successful Houston pilot
DEERFIELD, Ill. & CHICAGO, Dec. 2, 2020 – Walgreens Boots Alliance (Nasdaq: WBA) and VillageMD today announced plans to open the next 40 new Village Medical at Walgreens full-service primary care clinics by the end of summer 2021. The first markets for expansion include areas of Houston, El Paso and Austin, Texas, Phoenix, Ariz., and Orlando, Fla. The first new locations outside of Houston will open in the Phoenix area starting Dec. 14, 2020. The expansion is part of the large-scale rollout announced earlier this year to open 500 to 700 Village Medical at Walgreens clinics in more than 30 U.S. markets in the next five years.
“Walgreens is proud to partner with VillageMD to offer the most comprehensive and large-scale roll out of physician-led primary care services co-located in a retail pharmacy setting,” said Alex Gourlay co-chief operating officer, Walgreens Boots Alliance. “Our role as part of patient care teams has never been more critical, and our partnership with VillageMD enables us to provide more people with convenient access to high-quality, affordable care embedded in their communities.”
The new Village Medical at Walgreens clinics integrate pharmacists as critical members of VillageMD’s physician-led, multidisciplinary team to provide patients with a full suite of primary care and pharmacy services at convenient Walgreens neighborhood locations. By combining the expertise of both the physician and pharmacist, patients benefit from improved health outcomes and lowered cost of care.
With Village Medical board-certified physicians facilitating regular and direct communication between patients and Walgreens pharmacists, the model helps Village Medical at Walgreens patients take the right medications and get the right doses at the right times.
“In today’s complex healthcare environment, this integrated model of care is more important than ever. When patients adhere to the appropriate care and medication regime, health outcomes improve,” said Tim Barry, chairman and CEO at VillageMD. “At Village Medical at Walgreens, our experienced physicians and providers work closely with Walgreens pharmacists every day to ensure patients get accessible, personalized and coordinated care when they need it.”
Expansion plans were driven by the success of the first five clinics in Houston, indicated by overwhelmingly positive feedback and high satisfaction from both patients and physicians. With many clinics in medically underserved areas, Village Medical at Walgreens will help meet the needs of all people, including those who may not have access to healthcare and are at greater risk of health disparities.
The clinics will accept a wide range of health insurance options, offering cost-effective and comprehensive primary care to meet the full continuum of healthcare needs. Healthcare services are offered whenever and however patients need it, providing access to Village Medical care and support through in-person, at home and telehealth visits.
For more information about Village Medical at Walgreens services, please visit VillageMedical.com.
For more information as well as multimedia assets, please visit the Walgreens Newsroom.
Walgreens Boots Alliance (Nasdaq: WBA) is a global leader in retail and wholesale pharmacy, touching millions of lives every day through dispensing and distributing medicines, its convenient retail locations, digital platforms and health and beauty products. The company has more than 100 years of trusted health care heritage and innovation in community pharmacy and pharmaceutical wholesaling.
Including equity method investments, WBA has a presence in more than 25 countries, employs more than 440,000 people and has more than 18,750 stores.
WBA’s purpose is to help people across the world lead healthier and happier lives. The company is proud of its contributions to healthy communities, a healthy planet, an inclusive workplace and a sustainable marketplace. The company’s businesses have been recognized for their Corporate Social Responsibility. Walgreens was named to FORTUNE* magazine’s 2019 Companies that Change the World list and Boots UK was recognized as Responsible Business of the Year 2019-2020 by Business in the Community.
WBA is included in FORTUNE’s 2020 list of the World’s Most Admired Companies. This is the 27th consecutive year that WBA or its predecessor company, Walgreen Co., has been named to the list.
More company information is available at www.walgreensbootsalliance.com.
*© 2019, Fortune Media IP Limited. Used under license.
VillageMD, through its subsidiary Village Medical, is a leading, national provider of value-based primary care services. VillageMD partners with physicians to provide the tools, technology, operations, staffing support and industry relationships to deliver high-quality clinical care and better patient outcomes, while reducing the total cost of care. The Village Medical brand provides primary care for patients at traditional free-standing clinics, Village Medical at Walgreens clinics, at home and via virtual visits. VillageMD and Village Medical have grown to include more than 2,800 physicians across nine markets, are responsible for approximately 600,000 lives and manage $4 billion in total medical spend in value-based contracts. To learn more, please visit www.VillageMD.com.
Cautionary Note Regarding Forward-Looking Statements. All statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including, but not limited to, those related to the timing and effectiveness of collaboration plans and implementation, the ability to realize the anticipated benefits of the strategic partnership, competitive actions in the marketplace, and the ability to achieve anticipated financial and operating results in the amounts and at the times anticipated, as well as those described in Item 1A (Risk Factors) of Walgreens Boots Alliance, Inc.’s Form 10-K for its fiscal year ending August 31, 2019 and Form 10-Q for its fiscal quarter ending February 29, 2020, and in other documents that Walgreens Boots Alliance, Inc. files or furnishes with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially. These forward-looking statements speak only as of the date they are made. Each of Walgreens Boots Alliance, Inc., Walgreens and VillageMD do not undertake, and expressly disclaim, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions or otherwise.
Walgreens PR Contact:
VillageMD PR Contact: